Clinical Study on Weikang Capsules for Treatment of 56 Cases of Pyloric Helicobactorium-Related Peptic Ulcer

Ma Xijin~1; Yu Shiliang~2; Chen Ping~1; et al.

doi:10.13288/j.11-2166/r.2006.03.020

您当前的位置：

首页 >

文章列表页 >

Clinical Study on Weikang Capsules for Treatment of 56 Cases of Pyloric Helicobactorium-Related Peptic Ulcer

更新时间：2021-11-21

- Clinical Study on Weikang Capsules for Treatment of 56 Cases of Pyloric Helicobactorium-Related Peptic Ulcer
- Journal of Traditional Chinese Medicine Issue 3, Pages: 187-189(2006)
- 作者机构：
  
  1. 山东省临沂市沂水中心医院
  2. 山东省沂水县马站人民医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2006.03.020
  CLC： R259
- Published：2006
- 稿件说明：
移动端阅览
[1]马锡金,于世良,陈萍,陈兴田,任永昌,赵安成.胃康胶囊治疗幽门螺杆菌相关性消化性溃疡56例临床研究[J].中医杂志,2006(03):187-189.

Ma Xijin~1, Yu Shiliang~2, Chen Ping~1, et al. Clinical Study on Weikang Capsules for Treatment of 56 Cases of Pyloric Helicobactorium-Related Peptic Ulcer[J]. Journal of Traditional Chinese Medicine2006, (3): 187-189.
[1]马锡金,于世良,陈萍,陈兴田,任永昌,赵安成.胃康胶囊治疗幽门螺杆菌相关性消化性溃疡56例临床研究[J].中医杂志,2006(03):187-189. DOI： 10.13288/j.11-2166/r.2006.03.020.

Ma Xijin~1, Yu Shiliang~2, Chen Ping~1, et al. Clinical Study on Weikang Capsules for Treatment of 56 Cases of Pyloric Helicobactorium-Related Peptic Ulcer[J]. Journal of Traditional Chinese Medicine2006, (3): 187-189. DOI： 10.13288/j.11-2166/r.2006.03.020.

摘要

目的:探讨胃康胶囊对消化性溃疡的治疗作用及机理。方法:将106例确诊为幽门螺杆菌相关性消化性溃疡的患者随机分为治疗组与对照组

治疗组给予胃康胶囊

对照组给予雷尼替丁、丽珠得乐胶囊（CBS）、阿莫西林、甲硝唑治疗。观察两组临床症状、幽门螺杆菌根除率、胃黏膜血流量、镜下溃疡面愈合等情况的变化。结果:治疗组56例

临床总有效率为96.4%

幽门螺杆菌根除率为82.1%

镜下溃疡面愈合率为85.71%;对照组50例

临床总有效率为98.0%

幽门螺杆菌根除率为84.0%

镜下溃疡面愈合率为88.00%。两组比较差异无显著性（P>0.05）。结论:胃康胶囊对消化性溃疡有显著的治疗作用

其促进溃疡修复的机理可能与杀灭幽门螺杆菌、改善局部胃肠黏膜微循环

调节机体免疫机能等有关。

Abstract

Objective:To probe into therapeutic actions and mechanisms of Weikang Capsules in treatment of peptic ulcer.Methods:106 cases of Pyloric Helicobactorium（Hp）-related peptic ulcer were randomly divided into a treatment group（n=56） and a control group（n=50）.The treatment group were treated with Weikang Capsules and the control group with Ranitidine

Lizhu Dele Capsules（CBS）

Amoxicillin and Metrozine.Clinical symptoms

Hp eradication rate

blood flow volume of gastric mucosa

and the ulcer healing rate under microscope were investigated.Results:The clinical total effective rate

Hp eradication rate and ulcer healing rate was 96.4%

82.1% and 85.71% in the treatment group

and 98.0%

84.0% and 88.00% in the control group respectively

with no significant difference between the two groups（P>0.05）.Conclusion:Weikang Capsules have obvious therapeutic action on peptic ulcer

and the mechanism of promoting restoration of ulcer is possibly related with killing Hp

improving microcirculation of local mucosa

and regulating immunologic function of the organism.

关键词

Keywords

references

查看原文

Views

253

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effects of Weikang Capsule on Blood Nitric Oxide and Endothin-1 Contents in 120 Cases of Peptic Ulcer

Clinical and Experimental Study on Weiling Granule for Treatment of Peptic Ulcer

Clinical Study on Genyou Yuyang Capsule for Treatment of 100 Cases of Hp-related Peptic Ulcer

Thinking about Treatment of Helicobacter Pylorum Infection Related Gastrointestinal Diseases with TCM

Efficacy and Economic Evaluation of Weishi Qingjin Formula （苇石清金方）in the Treatment of Adult Community-Acquired Pneumonia with Phlegm-Heat Obstructing the Lung Syndrome：A Multicenter Retrospective Real-World Cohort Study

Related Author

郭斌

韩秋鑫

韩秋艳

林振川

谢振家

杨春波

吕方

何成龙

Related Institution

天津市中医药研究院附属医院脾胃科

内蒙古自治区林业总医院

内蒙古自治区林业总医院天津市和平区多伦道79号

天津市中医药研究院附属医院脾胃科内蒙古自治区林业总医院内蒙古自治区林业总医院天津市和平区多伦道79号

Quanzhou TCM Hospital

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰